Assess your muscle mass relative to height and body fat. FFMI is a superior metric to BMI for trained individuals, estimating lean mass independent of fat. Used by sports scientists, bodybuilders, and clinicians to evaluate body composition and anabolic potential.
The Fat-Free Mass Index (FFMI) was introduced by Kouri et al. (1995) to estimate lean muscle mass relative to height, independent of adipose tissue. Unlike BMI, which penalizes muscular individuals as “overweight”, FFMI separates fat mass from fat-free mass (muscle, bone, organs). It is widely adopted in sports medicine, anti-doping research, and physique assessment.
FFMI = Lean Body Mass (kg) / Height (m)²
Lean Mass = Weight × (1 – BodyFat% / 100)
Adjusted FFMI = FFMI + 6.1 × (1.8 – Height_m)
The adjustment accounts for height dependency: shorter individuals naturally have higher FFMI; the formula normalizes to a 1.8m reference.
In a landmark study, Kouri et al. (1995) found that natural bodybuilders had FFMI values below 25 (most under 22), while a majority of steroid users exceeded 25. Subsequent research (van der Ploeg et al., 2001) confirmed that an FFMI > 25 in males is highly suggestive of anabolic steroid use. For females, the natural ceiling is lower (~20). FFMI also correlates with muscular strength, bone mineral density, and metabolic health.
A 2018 systematic review in Sports Medicine reaffirmed FFMI as a reliable surrogate for lean mass when direct methods (DEXA, MRI) are unavailable. The adjusted FFMI reduces height bias and improves cross-sectional comparisons. Moreover, a low FFMI (<16 in men, <14 in women) is associated with sarcopenia, frailty, and increased mortality risk in clinical populations. For athletic monitoring, FFMI changes track muscle gain more accurately than body weight alone.
| Category (Male) | FFMI (unadjusted) | Adjusted FFMI (1.8m ref) | Implication |
|---|---|---|---|
| Below average / low muscle mass | < 17 | < 17 | Possible underweight or sarcopenia |
| Average healthy male | 17 – 19 | 17 – 19 | Normal range, average physique |
| Trained / athletic | 19 – 21 | 19 – 21 | Regular resistance training |
| Elite natural bodybuilder | 21 – 23 | 21 – 23 | Genetic potential near natural limit |
| Suspicious of enhancement | > 23 | > 24 (male) | Indicative of anabolic use (research-backed) |
For females, subtract approximately 3–4 points from male cutoffs (natural elite ~19-20).
A 28-year old male athlete: 178 cm, 86 kg, 10% body fat → Lean mass = 77.4 kg, FFMI = 24.4. According to Kouri's data, this approaches the upper natural limit (~25). Most tested natural professionals score below 24. This calculator helps athletes set realistic drug-free muscle goals and detect potential health risks associated with excessive lean mass (cardiovascular strain).
The correction factor 6.1 was derived from a regression analysis of 239 healthy males (Kouri et al., 1995). The formula FFMI_adj = FFMI + 6.1 × (1.8 – Ht_m) yields a height‑standardized index. Without adjustment, a 170 cm and 190 cm individual with identical lean mass would have FFMI differing by ~2.5 units, obscuring true muscularity. The adjusted FFMI is the recommended metric for scientific communication and anti‑doping screening (see PIED research).
Due to hormonal and anatomical differences, women naturally have lower FFMI. Based on reference data from the National Health and Nutrition Examination Survey (NHANES), the 90th percentile for young active females is approximately 18.5. Elite female athletes (soccer, track, physique) rarely exceed 20 FFMI without pharmacological intervention. The calculator applies female thresholds: <14 (low), 14–16 (average), 16–18 (trained), 18–20 (elite natural), >20 (exceptional). Always interpret in context of sport and individual genetics.
Since FFMI scales inversely with height (shorter people have higher FFMI for the same lean mass), the adjusted FFMI uses a linear correction: FFMI_adjusted = FFMI + 6.1 × (1.8 – Ht_m). This normalizes all individuals to a height of 1.8 meters, enabling fair comparisons between athletes of different statures. The correction coefficient (6.1) was derived from regression analysis of healthy populations.